Home - Products - Others - Other Targets - Adrenocorticotropic Hormone (ACTH) (1-39) human

Adrenocorticotropic Hormone (ACTH) (1-39) human

CAS No. 12279-41-3

Adrenocorticotropic Hormone (ACTH) (1-39) human ( —— )

Catalog No. M21629 CAS No. 12279-41-3

Adrenocorticotropic Hormone (ACTH) (1-39) human is an?agonist of melanocortin receptor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 266 Get Quote
5MG 441 Get Quote
10MG 651 Get Quote
25MG 1017 Get Quote
50MG 1368 Get Quote
100MG 1782 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Adrenocorticotropic Hormone (ACTH) (1-39) human
  • Note
    Research use only not for human use.
  • Brief Description
    Adrenocorticotropic Hormone (ACTH) (1-39) human is an?agonist of melanocortin receptor.
  • Description
    Adrenocorticotropic Hormone (ACTH) (1-39) human is an?agonist of melanocortin receptor.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    12279-41-3
  • Formula Weight
    4541.07
  • Molecular Formula
    C207H308N56O58S1
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lisak RP et al. Melanocortin receptor agonist ACTH 1-39 protects rat forebrain neurons from apoptotic excitotoxic and inflammation-related damage. Exp Neurol. 2015 Nov;273:161-7.
molnova catalog
related products
  • Diclofenac Epolamine

    Diclofenac Epolamine is a non-steroidal anti-inflammatory agent (NSAID) with analgesic and antipyretic actions.

  • (-)-Lyoniresinol 9-O...

    (-)-Lyoniresinol 9'-O-glucoside is a natural product from Phyllostachys heterocycla MITF.

  • Somatostatin 1-28

    Somatostatin receptor agonist, derived from the post-translational cleavage of prosomatostatin.